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FOCUS ON . . .metastasis suppressorsCancer patients very often experience spread of tumor cells to
secondary locations far-removed from the primary tumor center.
In fact more than 90% of cancer deaths are caused by disseminating
tumor cells [1]. Research of the last years identiﬁed various steps of
the metastatic cascade that includes cell invasion, survival in vas-
cular and lymphatic space and colonization and tumor progression
in distant organs. These steps are regulated by a class of metastasis
effector genes both positively and negatively [2]. Genes that inhibit
metastasis but do not affect primary tumor development are called
metastasis suppressor genes. This FOCUS ON . . .assembles a series
of mini-reviews providing perspective on some of these genes, on
the function of their products and therapeutic efﬁcacy of their
targeting.
Jacobs and Sackstein [1] describe how circulating tumor cells
use normal leukocyte trafﬁcking to home speciﬁc tissues and the
role of hematopoietic cell E-/L-selectin (HCELL), a sialofucosylated
glycoform of CD44, in tumor cell-endothelium, leukocyte and
platelet interaction. Knopeke et al. [3] highlight the biological
mechanism of action of MAP kinase kinase 4 (MKK4), speciﬁcally
its valuable use in disrupting tumor cell-microenvironment inter-
actions to elucidate the requirements for metastatic colonization
and developing models to allow the study on early steps of
dormancy. Tsai and Weissman [4] are dealing with the multiple
mechanisms implicated in metastasis suppression by CD82/KAI1,
a member of the tetraspanin superfamily of glycoproteins affecting
membrane organization, protein interactions and hence cell signal-
ing and intercellular communication. The Nm23 family of metasta-
sis-associated genes particularly the Nm23-H1 anti-metastatic
factor is in focus of Saha and Roberts’ contribution [5]. Nm23-H1
has clearly been suggested to play a pivotal role in limiting tumor
cell motility and progression induced by several tumor viruses
including Epstein-Barr virus, Kaposi-associated herpes virus and
human papilloma virus. Finally, Hurst and Welch [6] review func-
tional aspects of the breast cancer metastasis suppressor 10014-5793/$36.00  2011 Published by Elsevier B.V. on behalf of the Federation of Euro
doi:10.1016/j.febslet.2011.09.022(BRMS1), the expression of which causes dramatic metastasis sup-
pression in various in vivo model systems. Thereby, BRMS1 associ-
ates with chromatin-remodeling complexes, such as SIN3:HDAC
known to be powerful epigenetic regulators of gene expression.
Furthermore, the authors consider how BRMS1 coordinately regu-
lates expression of the metastasis-associated micro-RNA known as
metastamir.
This FOCUS ON . . .aims at a better understanding of the evolving
mechanisms of metastatic regulation and the functions metastasis
suppressor proteins exert in this process. The editor greatly thanks
the authors for contributing to this exciting mini-review series and
both editor and authors hope that this FOCUS ON . . .will further
challenge the metastatic aspect of cancer research.References
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